| Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients P Brasnyó, GA Molnár, M Mohás, L Markó, B Laczy, J Cseh, E Mikolás, ... British journal of nutrition 106 (3), 383-389, 2011 | 783 | 2011 |
| Pivotal role of Akt activation in mitochondrial protection and cell survival by poly (ADP-ribose) polymerase-1 inhibition in oxidative stress A Tapodi, B Debreceni, K Hanto, Z Bognar, I Wittmann, F Gallyas, ... Journal of Biological Chemistry 280 (42), 35767-35775, 2005 | 202 | 2005 |
| The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics DC Wheeler, BV Stefansson, M Batiushin, O Bilchenko, DZI Cherney, ... Nephrology Dialysis Transplantation 35 (10), 1700-1711, 2020 | 161 | 2020 |
| Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study Z Vokó, Z Kiss, G Surján, O Surján, Z Barcza, B Pályi, E Formanek-Balku, ... Clinical Microbiology and Infection 28 (3), 398-404, 2022 | 137 | 2022 |
| Measurement of von Willebrand factor as the marker of endothelial dysfunction in vascular diseases B Horvath, D Hegedus, L Szapary, Z Marton, T Alexy, K Koltai, L Czopf, ... Experimental & Clinical Cardiology 9 (1), 31, 2004 | 133 | 2004 |
| Nϵ-(carboxymethyl) lysine levels in patients with type 2 diabetes: Role of renal function Z Wagner, I Wittmann, I Mazák, R Schinzel, A Heidland, R Kientsch-Engel, ... American journal of kidney diseases 38 (4), 785-791, 2001 | 132 | 2001 |
| Serum carboxymethyllysine predicts mortality in hemodialysis patients Z Wagner, M Molnár, GA Molnár, M Tamaskó, B Laczy, L Wagner, B Csiky, ... American journal of kidney diseases 47 (2), 294-300, 2006 | 103 | 2006 |
| Inhibition of O-GlcNAcase in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc-dependent manner B Laczy, SA Marsh, CA Brocks, I Wittmann, JC Chatham American Journal of Physiology-Heart and Circulatory Physiology 299 (5 …, 2010 | 101 | 2010 |
| Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis B Racz, B Gasz, B Borsiczky, F Gallyas Jr, A Tamas, R Jozsa, A Lubics, ... General and comparative endocrinology 153 (1-3), 115-123, 2007 | 85 | 2007 |
| Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome A Maasz, P Kisfali, K Horvatovich, M Mohás, L Markó, V Csöngei, ... Pathology & Oncology Research 13, 243-247, 2007 | 83 | 2007 |
| Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure: evidence for hydroxyl radical production GA Molnár, Z Wagner, L Markό, M Mohás, B Kocsis, Z Matus, L Wagner, ... Kidney International 68 (5), 2281-2287, 2005 | 78 | 2005 |
| Prevalence, course and risk factors of diabetic nephropathy in type-2 diabetes mellitus M Molnár, I Wittmann, J Nagy Med Sci Monit 6 (5), 929-936, 2000 | 78 | 2000 |
| Accumulation of the hydroxyl free radical markers meta-, ortho-tyrosine and DOPA in cataractous lenses is accompanied by a lower protein and phenylalanine content of the water … GA Molnár, V Nemes, Z Biró, A Ludány, Z Wagner, I Wittmann Free Radical Research 39 (12), 1359-1366, 2005 | 70 | 2005 |
| Evidence of O-linked N-acetylglucosamine in diabetic nephropathy P Degrell, J Cseh, M Mohás, GA Molnár, L Pajor, JC Chatham, N Fülöp, ... Life sciences 84 (13-14), 389-393, 2009 | 67 | 2009 |
| Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in … DC Wheeler, N Jongs, BV Stefansson, GM Chertow, T Greene, FF Hou, ... Nephrology Dialysis Transplantation 37 (9), 1647-1656, 2022 | 61 | 2022 |
| A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt … HJL Heerspink, D Cherney, D Postmus, BV Stefánsson, GM Chertow, ... Kidney international 101 (1), 174-184, 2022 | 61 | 2022 |
| Similarities in serum acylcarnitine patterns in type 1 and type 2 diabetes mellitus and in metabolic syndrome J Bene, M Márton, M Mohás, Z Bagosi, Z Bujtor, T Oroszlán, B Gasztonyi, ... Annals of nutrition and metabolism 62 (1), 80-85, 2013 | 60 | 2013 |
| Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome P Kisfali, M Mohás, A Maász, N Polgar, F Hadarits, L Markó, P Brasnyó, ... Nutrition, Metabolism and Cardiovascular Diseases 20 (7), 505-511, 2010 | 50 | 2010 |
| Enrichment of Amadori products derived from the nonenzymatic glycation of proteins using microscale boronate affinity chromatography A Takátsy, K Böddi, L Nagy, G Nagy, S Szabó, L Markó, I Wittmann, ... Analytical biochemistry 393 (1), 8-22, 2009 | 50 | 2009 |
| GCKR gene functional variants in type 2 diabetes and metabolic syndrome: do the rare variants associate with increased carotid intima-media thickness? M Mohás, P Kisfali, L Járomi, A Maász, E Fehér, V Csöngei, N Polgár, ... Cardiovascular Diabetology 9, 1-7, 2010 | 49 | 2010 |
